MDxHealth SA provided revenue guidance for the Full year 2022. For the Year, Company expects revenue of $25 million to $27 million, representing growth of 13% to 21% over full year 2021 revenue of $22.2 million.
MDxHealth SA Euronext Bruxelles
Equities
MDXH
BE0974461940
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+25.73% | 42.68B | |
-3.00% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.53% | 24.94B | |
-20.12% | 18.96B | |
+28.96% | 12.3B | |
-2.72% | 11.95B | |
-1.50% | 11.55B |